MarketWise (MKTW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
A special meeting of stockholders is scheduled for March 20, 2025, to vote on key proposals including a reverse stock split and a reduction in authorized shares.
The reverse stock split aims to address Nasdaq non-compliance due to a low share price and improve marketability and liquidity.
The Board unanimously recommends voting in favor of all proposals and retains discretion to implement or abandon them.
Forward-looking statements highlight risks and uncertainties, especially regarding the impact of the reverse split and potential Nasdaq delisting.
Voting matters and shareholder proposals
Proposal 1: Approve a 1-for-20 reverse stock split, with implementation and timing at the Board's discretion.
Proposal 2: Approve a reduction in authorized shares of all classes, contingent on the reverse split.
Proposal 3: Approve adjournment of the meeting if more time is needed to solicit votes.
All proposals require a majority vote; abstentions and broker non-votes may impact outcomes differently by proposal.
Board of directors and corporate governance
The Board has the authority to implement or abandon the reverse split and authorized share reduction at its discretion.
Board members and executive officers have interests in the proposals due to their shareholdings, but these are not deemed different from other stockholders.
Latest events from MarketWise
- Q4 2025 billings surged 42% YoY, FY 2026 guidance raised, and dividends increased.MKTW
Q4 20256 Mar 2026 - Q4 2024 saw a return to billings growth, improved margins, and renewed strategic focus.MKTW
Emerging Growth Conference 7810 Jan 2026 - Shareholders to vote on director elections, equity plan amendment, and new auditor ratification.MKTW
Proxy Filing1 Dec 2025 - Vote on reverse stock split and share reduction to maintain Nasdaq listing and streamline capital structure.MKTW
Proxy Filing1 Dec 2025 - Key votes include director elections, incentive plan amendment, and auditor ratification.MKTW
Proxy Filing1 Dec 2025 - Q3 2025 net income was $17.9M on $81.3M revenue, with ARPU up 35.5% and a buyout proposal pending.MKTW
Q3 20256 Nov 2025 - Q2 2025 saw revenue and subscribers fall, but cash flow, billings, and capital returns strengthened.MKTW
Q2 20257 Aug 2025 - Net income rose to $22.7M in Q3 2024 despite sharp declines in revenue and subscribers.MKTW
Q3 202413 Jun 2025 - Net income surged to $21.2M in Q2 2024, while billings fell 40% amid Legacy Research wind-down.MKTW
Q2 202413 Jun 2025